Designing highly functional and specific guide RNAs for knockout and achieving precise knockin using the homology-directed repair pathway
Poster Mar 24, 2017 | Poster from Dharmacon (part of GE Healthcare)
Melissa L. Kelley, Emily M. Anderson, Shawn McClelland, Elena Maksimova, Tyler Reed, Steve Lenger, Žaklina Strezoska, Hidevaldo Machado, Eldon Chou, Maren Mayer, John Schiel and Anja van Brabant Smith from Dharmacon, part of GE Healthcare, 2650 Crescent Drive, Suite #100, Lafayette, CO 80026, US
The CRISPR-Cas9 system requires a Cas9 nuclease and two short RNAs, a crRNA and tracrRNA, to introduce double-strand breaks for functional protein disruption (knockout) or for insertion or replacement of genetic content, such as a selection marker (knockin). Our approach to better understand the parameters affecting CRISPR-Cas9 editing efficiency for functional gene knockout utilized synthetic crRNAs and tracrRNA, which can be chemically synthesized rapidly without the need for cloning and sequencing. We systematically transfected > 1100 synthetic crRNA:tracrRNAs into a GFP-reporter cell line to develop an algorithm to predict functional gene knockout. To minimize potential off-targets, we developed a rigorous specificity tool that is able to detect mismatches as well as gapped alignments that are typically missed using most existing specificity tools. Together, we are able to design highly functional and specific guide RNAs. In addition, we have expanded the use of synthetic crRNA:tracrRNA by demonstrating its utility in knockin applications using short single-stranded DNA as donor templates for small insertions, such as SNPs, or DNA vectors as donor templates for large insertions, such as a GFP reporter. Finally, we provide guidelines for design of these donor templates for optimal knockin efficiency.
Despite the developments in conventional PCR, the complexity of multiplex Real Time PCR is still limited due to the lack of sufficient detection channels. To achieve high-end multiplexing capacity on standard Real Time PCR machines, Anapa Biotech has developed the MeltPlex® technology (see box on right).READ MORE
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE